HRP20050376A2 - Novel process for the preparation of imidazolyl compounds - Google Patents

Novel process for the preparation of imidazolyl compounds

Info

Publication number
HRP20050376A2
HRP20050376A2 HR20050376A HRP20050376A HRP20050376A2 HR P20050376 A2 HRP20050376 A2 HR P20050376A2 HR 20050376 A HR20050376 A HR 20050376A HR P20050376 A HRP20050376 A HR P20050376A HR P20050376 A2 HRP20050376 A2 HR P20050376A2
Authority
HR
Croatia
Prior art keywords
hydrogen
alkyl
compound
optionally substituted
following formula
Prior art date
Application number
HR20050376A
Other languages
English (en)
Croatian (hr)
Inventor
Verbeek Jan-Maarten
Paulus
Original Assignee
Solvay Pharmaceuticals B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals B.V. filed Critical Solvay Pharmaceuticals B.V.
Publication of HRP20050376A2 publication Critical patent/HRP20050376A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20050376A 2002-11-18 2005-04-28 Novel process for the preparation of imidazolyl compounds HRP20050376A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079838 2002-11-18
PCT/EP2003/050841 WO2004046116A1 (en) 2002-11-18 2003-11-17 Novel process for the preparation of imidazolyl compounds

Publications (1)

Publication Number Publication Date
HRP20050376A2 true HRP20050376A2 (en) 2006-02-28

Family

ID=32319633

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050376A HRP20050376A2 (en) 2002-11-18 2005-04-28 Novel process for the preparation of imidazolyl compounds

Country Status (25)

Country Link
EP (1) EP1565445B1 (de)
JP (1) JP4611026B2 (de)
KR (1) KR20050075026A (de)
CN (1) CN100349873C (de)
AR (1) AR041955A1 (de)
AT (1) ATE340783T1 (de)
AU (1) AU2003296762B2 (de)
BR (1) BR0316308A (de)
CA (1) CA2504614C (de)
DE (1) DE60308720T2 (de)
DK (1) DK1565445T3 (de)
ES (1) ES2273088T3 (de)
HK (1) HK1081188A1 (de)
HR (1) HRP20050376A2 (de)
IL (1) IL168258A (de)
MX (1) MXPA05005261A (de)
NO (1) NO330342B1 (de)
PL (1) PL376743A1 (de)
PT (1) PT1565445E (de)
RU (1) RU2314296C2 (de)
SA (1) SA03240414B1 (de)
SI (1) SI1565445T1 (de)
UA (1) UA79655C2 (de)
WO (1) WO2004046116A1 (de)
ZA (1) ZA200503425B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.

Also Published As

Publication number Publication date
IL168258A (en) 2010-05-31
SA03240414B1 (ar) 2006-12-05
JP4611026B2 (ja) 2011-01-12
WO2004046116A1 (en) 2004-06-03
SI1565445T1 (sl) 2007-02-28
ZA200503425B (en) 2007-02-28
CA2504614A1 (en) 2004-06-03
MXPA05005261A (es) 2005-07-25
DK1565445T3 (da) 2007-01-29
PL376743A1 (pl) 2006-01-09
NO20052950D0 (no) 2005-06-16
CA2504614C (en) 2010-09-28
KR20050075026A (ko) 2005-07-19
CN100349873C (zh) 2007-11-21
EP1565445B1 (de) 2006-09-27
ATE340783T1 (de) 2006-10-15
DE60308720T2 (de) 2007-01-11
EP1565445A1 (de) 2005-08-24
PT1565445E (pt) 2007-01-31
RU2314296C2 (ru) 2008-01-10
HK1081188A1 (en) 2006-05-12
AU2003296762B2 (en) 2010-03-18
UA79655C2 (en) 2007-07-10
AR041955A1 (es) 2005-06-01
RU2005119155A (ru) 2006-01-20
NO330342B1 (no) 2011-03-28
ES2273088T3 (es) 2007-05-01
NO20052950L (no) 2005-08-15
BR0316308A (pt) 2005-09-27
CN1714082A (zh) 2005-12-28
DE60308720D1 (de) 2006-11-09
AU2003296762A1 (en) 2004-06-15
JP2006512322A (ja) 2006-04-13

Similar Documents

Publication Publication Date Title
RS54199B1 (en) PROCEDURE FOR OBTAINING INTERMEDIERS OF USEFUL USES AS OPIOID RECEPTOR MODULATORS
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
SE9904850D0 (sv) Novel process and intermediates
NO330983B1 (no) Fremgangsmate for fremstilling av pyrimidinderivater
DK200101216A (da) Fremgangsmåde til fremstilling af citalopram
NZ597538A (en) Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives
NO20081167L (no) Fluoriseringsframgangsmate
MX2010003148A (es) Procedimiento para la preparacion de diamidas de acido sulfonico.
RS50663B (sr) Postupci za dobijanje 3-o-zaštićenih morfinona i 3-o-zaštićenih morfinon dienol karboksilata
DK1601653T3 (da) Fremgangsmåde til fremstilling af substituerede nikotinsyreestre
RS54309B1 (en) DIHYDROETHORPHINS AND THEIR PREPARATION
DK1246812T3 (da) Fremgangsmåde til fremstilling af citalopram
RU2016125459A (ru) Способ получения хиральных 2-арилморфолинов
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
TR200202096T2 (tr) Sitalopram hazırlamak için yöntem
ATE428693T1 (de) Prostaglandinsynthese
WO2008103367A3 (en) Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
BR0212982A (pt) Processo para preparar um composto, e, composto
NO20081859L (no) Fremgangsmate for fremstillingen av sartanderivater og mellomprodukter som er nyttige i slike fremgangsmater
HRP20050376A2 (en) Novel process for the preparation of imidazolyl compounds
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
HUP0200808A2 (hu) Eljárás a piperazingyűrű kialakítására és új piperazinszármazékok
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20101109

Year of fee payment: 8

OBST Application withdrawn